Kalmar Investments’s Globus Medical GMED Stock Holding History

Kalmar Investments’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$4.6M	Sell	155,218 -393,945	-72%	-$10.8M	1.04%	52
2016 Q4	$13.6M	Sell	549,163 -488,174	-47%	-$11.1M	0.7%	74
2016 Q3	$23.4M	Sell	1,037,337 -79,110	-7%	-$1.86M	1.07%	32
2016 Q2	$26.6M	Sell	1,116,447 -325,268	-23%	-$7.8M	1.17%	30
2016 Q1	$34.2M	Sell	1,441,715 -337,320	-19%	-$8.25M	1.41%	20
2015 Q4	$49.5M	Sell	1,779,035 -69,492	-4%	-$1.74M	1.21%	23
2015 Q3	$38.2M	Sell	1,848,527 -31,656	-2%	-$802K	0.9%	48
2015 Q2	$48.3M	Sell	1,880,183 -68,260	-4%	-$1.73M	0.91%	44
2015 Q1	$49.2M	Buy	1,948,443 +8,023	+0.4%	+$195K	0.91%	47
2014 Q4	$46.1M	Buy	+1,940,420	New	+$43M	0.86%	45

Other funds holding GMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

AAM

Aberdeen Asset Management Aberdeen, United Kingdom $30B AUM 22.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Kalmar Investments's GMED Position: Q1 2017 in Review

Kalmar Investments reduced its Globus Medical (GMED) stake by 72% in Q1 2017, selling an estimated $10.8M and leaving 155,218 shares worth $4.6M. The position accounts for 1.04% of the portfolio, ranked #52.

Kalmar Investments first reported a position in GMED in Q4 2014 and has held it in 10 quarters since. The position peaked at $49.5M in Q4 2015. 243 funds tracked by Wall St. Rank hold GMED as of Q1 2017.

Kalmar Investments held 155,218 shares of Globus Medical worth $4.6M as of Q1 2017.
Kalmar Investments sold 393,945 Globus Medical shares in Q1 2017, an estimated $10.8M.
Globus Medical made up 1.04% of Kalmar Investments's portfolio in Q1 2017, its #52 holding.
Kalmar Investments first reported a position in Globus Medical in Q4 2014 and has held it in 10 quarters since.
Kalmar Investments's Globus Medical position peaked at $49.5M in Q4 2015.
243 funds tracked by Wall St. Rank held Globus Medical as of Q1 2017.

Based on Kalmar Investments's 13F filing for Q1 2017, filed 26 Apr 2017.